California Public Employees Retirement System’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-158,802
Closed -$1.6M 1218
2022
Q4
$1.6M Sell
158,802
-17,402
-10% -$327K ﹤0.01% 1192
2022
Q3
$3.95M Buy
176,204
+37,856
+27% +$1.09M ﹤0.01% 1151
2022
Q2
$3.43M Hold
138,348
﹤0.01% 1131
2022
Q1
$5.36M Sell
138,348
-22,597
-14% -$875K ﹤0.01% 1119
2021
Q4
$9.42M Sell
160,945
-20,502
-11% -$1.16M 0.01% 1005
2021
Q3
$10.8M Buy
181,447
+2,722
+2% +$214K 0.01% 964
2021
Q2
$15.5M Sell
178,725
-1,952
-1% -$157K 0.01% 792
2021
Q1
$14.9M Buy
180,677
+7,790
+5% +$746K 0.01% 820
2020
Q4
$15.7M Buy
172,887
+10,807
+7% +$671K 0.01% 765
2020
Q3
$6.48M Buy
162,080
+23,560
+17% +$823K 0.01% 1080
2020
Q2
$4.75M Buy
138,520
+3,374
+2% +$101K ﹤0.01% 1233
2020
Q1
$3M Buy
135,146
+11,211
+9% +$284K ﹤0.01% 1346
2019
Q4
$2.42M Sell
123,935
-28,979
-19% -$460K ﹤0.01% 1923
2019
Q3
$2.38M Buy
152,914
+92,628
+154% +$1.78M ﹤0.01% 1784
2019
Q2
$1.22M Buy
60,286
+5,470
+10% +$98.6K ﹤0.01% 2031
2019
Q1
$963K Sell
54,816
-3,368
-6% -$53.2K ﹤0.01% 2244
2018
Q4
$747K Hold
58,184
﹤0.01% 2378
2018
Q3
$948K Buy
58,184
+41,191
+242% +$487K ﹤0.01% 2356
2018
Q2
$193K Buy
+16,993
New +$187K ﹤0.01% 3016

Other funds holding FATE

California Public Employees Retirement System's FATE Position: Q1 2023 in Review

California Public Employees Retirement System sold out of Fate Therapeutics (FATE) in Q1 2023, closing a stake of 158,802 shares — an estimated $1.6M sold.

California Public Employees Retirement System first reported a position in FATE in Q2 2018 and held it in 19 quarters. The position peaked at $15.7M in Q4 2020. 181 funds tracked by Wall St. Rank hold FATE as of Q1 2023.

  • California Public Employees Retirement System reported no remaining Fate Therapeutics position as of Q1 2023 after selling out during the quarter.
  • California Public Employees Retirement System sold 158,802 Fate Therapeutics shares in Q1 2023, an estimated $1.6M.
  • California Public Employees Retirement System first reported a position in Fate Therapeutics in Q2 2018 and held it in 19 quarters.
  • California Public Employees Retirement System's Fate Therapeutics position peaked at $15.7M in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2023.

Based on California Public Employees Retirement System's 13F filing for Q1 2023, filed 12 May 2023.